| CDTX |
Cidara Therapeutics, Inc. |
07 Jan 2026 |
12 |
-$33,225 |
4 |
Director |
07 Jan 2026, 20:17 |
| CDTX |
Cidara Therapeutics, Inc. |
18 Jun 2025 |
1 |
$0 |
4 |
Director |
18 Jun 2025, 17:03 |
| CDTX |
Cidara Therapeutics, Inc. |
17 Dec 2024 |
1 |
$0 |
4 |
Director |
19 Dec 2024, 18:20 |
| CDTX |
Cidara Therapeutics, Inc. |
18 Jul 2024 |
1 |
$0 |
4 |
Director |
19 Jul 2024, 16:56 |
| ABUS |
Arbutus Biopharma Corp |
23 May 2024 |
1 |
$0 |
4 |
Director |
24 May 2024, 16:17 |
| CDTX |
Cidara Therapeutics, Inc. |
22 Jun 2023 |
1 |
$0 |
4 |
Director |
23 Jun 2023, 17:19 |
| ABUS |
Arbutus Biopharma Corp |
24 May 2023 |
1 |
$0 |
4 |
Director |
26 May 2023, 16:22 |
| /report/000110465922086282-burgess-daniel-d-2022-08-02 |
Nabriva Therapeutics plc |
02 Aug 2022 |
1 |
-$2,156 |
4 |
Director |
04 Aug 2022, 18:24 |
| CDTX |
Cidara Therapeutics, Inc. |
22 Jun 2022 |
1 |
$0 |
4 |
Director |
24 Jun 2022, 17:33 |
| ABUS |
Arbutus Biopharma Corp |
25 May 2022 |
1 |
$0 |
4 |
Director |
26 May 2022, 16:17 |
| /report/000110465921100290-burgess-daniel-d-2021-08-02 |
Nabriva Therapeutics plc |
02 Aug 2021 |
1 |
-$1,350 |
4 |
Director |
04 Aug 2021, 21:07 |
| /report/000110465921098429-burgess-daniel-d-2021-07-28 |
Nabriva Therapeutics plc |
28 Jul 2021 |
2 |
$0 |
4 |
Director |
30 Jul 2021, 20:23 |
| CDTX |
Cidara Therapeutics, Inc. |
23 Jun 2021 |
1 |
$0 |
4 |
Director |
24 Jun 2021, 17:55 |
| ABUS |
Arbutus Biopharma Corp |
03 Jun 2021 |
1 |
$0 |
4 |
Director |
07 Jun 2021, 16:25 |